Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
This study has been terminated.
(recruitment goals met)
Sponsor:
University of Michigan Cancer Center
Collaborator:
Eli Lilly and Company
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00148135
First received: September 2, 2005
Last updated: December 28, 2007
Last verified: December 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | October 2007 |
| Primary Completion Date: | April 2006 (Final data collection date for primary outcome measure) |